Tuberculosis prevalence and associated factors among persons infected with human immunodeficiency virus in three West African countries (Benin, Guinea, Senegal)
Keywords:
Tuberculosis; PLHIV; burden; risk factors; West AfricaAbstract
Background: Tuberculosis (TB) is a leading cause of morbidity and mortality in people living with human immunodeficiency virus (HIV). Data are very scarce on the burden of TB in HIV patients in Sub-saharan African populations. This study aimed to determine the prevalence of pulmonary tuberculosis (PTB) and associated factors among people living with human immunodeficiency virus (HIV) in three West African countries: Benin, Guinea, and Senegal.
Methods: A cross-sectional study was conducted among people living with HIV in three outpatient care centres (one in each country). All HIV-positive patients included in this study were routinely screened for PTB using microscopy, GeneXpert and culture. Participants free of TB were reassessed clinically and biologically six months later. Data were analyzed using R-3.4.3 software. Logistic regression was used to identify factors associated with PTB.
Results: A total of 2859 participants were enrolled in the study, of whom 2820 were screened for TB, 1000 were ARV-naive (35.46%), and 1820 were on ARV prior to screening (64.54%). A total of 127 cases of bacteriologically confirmed PTB (BCPTB) were diagnosed: 117 at baseline and 10 at the 6-month visit. The overall prevalence of BCPTB was 7.90% [95% CI: 6.38-9.75] for ARV-naive participants and 2.64% [95% CI: 1.99-3.48] for participants on ARV at the time of screening. Participants from Guinea were more likely to be diagnosed with TB (OR: 2.95 [95% CI: 1.60-5.45], p=0.001). Underweight HIV-positive patients had higher odds of TB diagnosis (OR: 2.09 [95% CI: 1.40-3.12], p<0.001), while overweight/obesity was associated with lower odds of TB (OR: 0.35 [95% CI: 0.15-0.81], p=0.015). Other factors associated with BCPTB in HIV patients were male sex (OR: 1.81 [95% CI: 1.18-2.77], p=0.007), CD4 count <200/ml (OR: 2.24 [95% CI: 1.15-4.37], p=0.018), and irregular disease follow-up (OR: 2.57 [95% CI: 1.29-5.15], p=0.018).
Conclusion: The prevalence of TB among people living with HIV is high in Benin, Guinea and Senegal. These results highlight the need to improve TB screening and diagnosis in PLHIV, especially in ARV-naive patients.
References
1. Zumla A, Petersen E, Nyirenda T, Chakaya J. Tackling the tuberculosis epidemic in sub-Saharan Africa – unique opportunities arising from the second European Developing Countries Clinical Trials Partnership programme 2015–2024. Int J Infect Dis 2015;32:46–9.
2. World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization; 2013.
3. Loveday M, Zweigenthal V. TB and HIV integration: obstacles and possible solutions to implementation in South Africa. Trop Med Int Health 2011;16:431–8.
4. Tesfaye B, Alebel A, Gebrie A, Zegeye A, Tesema C, Kassie B. The twin epidemics: prevalence of TB/HIV co-infection and its associated factors in Ethiopia; a systematic review and meta-analysis. PLoS One 2018;13:e0203986.
5. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010;362:697–706.
6. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection–associated tuberculosis: the epidemiology and the response. Clin Infect Dis 2010;50:S201–7.
7. Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A. Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J 2010;36(6):1460–81.
8. Omar T, Variava E, Moroe E, Billioux A, Chaisson R, Lebina L, et al. Undiagnosed TB in adults dying at home from natural causes in a high TB burden setting: a post-mortem study. Int J Tuberc Lung Dis 2015;19:1320–5.
9. Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS 2015;29:1987–2002.
10. Yang Q, Han J, Shen J, Peng X, Zhou L, Yin X. Diagnosis and treatment of tuberculosis in adults with HIV. Medicine (Baltimore) 2022;101:e30176.
11. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011. Available from: https://apps.who.int/iris/handle/10665/44472
12. Kranzer K, Houben RM, Glynn JR, Bekker LG, Wood R, Lawn SD. Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:93–102.
13. World Bank Open Data. Prevalence of HIV, total (% of population ages 15–49). Available from: https://data.worldbank.org
14. World Health Organization. Tuberculosis country profiles. 2019. Available from: https://worldhealthorg.shinyapps.io/tb_profiles/
15. Wachinou AP, Ade S, Mbaye MN, Bah B, Baldé N, Gninkoun J, et al. Tuberculosis prevalence and associated factors among persons with diabetes mellitus after intensified case finding in three West African countries. Multidiscip Respir Med 2021;16:712.
16. World Health Organization. Systematic screening for active tuberculosis: an operational guide. Geneva: World Health Organization; 2015. Available from: https://apps.who.int/iris/handle/10665/181164
17. World Health Organization. TB diagnostics and laboratory services, information note. Available from: https://www.who.int/tb/dots/lab.pdf
18. World Health Organization. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. Available from: https://apps.who.int/iris/handle/10665/77741
19. Brennan A, Maskew M, Larson BA, Tsikhutsu I, Bii M, Vezi L, et al. Prevalence of TB symptoms, diagnosis and treatment among people living with HIV not on ART presenting at outpatient clinics in South Africa and Kenya: baseline results from a clinical trial. BMJ Open 2020;10:e035794.
20. Bajema KL, Bassett IV, Coleman SM, Ross D, Freedberg KA, Wald A, et al. Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort. BMC Infect Dis 2019;19:23.
21. Ngowi BJ, Mfinanga SG, Bruun JN, Morkve O. Pulmonary tuberculosis among people living with HIV/AIDS attending care and treatment in rural northern Tanzania. BMC Public Health 2008;8:341.
22. Iliyasu Z, Babashani M. Prevalence and predictors of tuberculosis coinfection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, northern Nigeria. J Epidemiol 2009;19:81–7.
23. Assefa D, Melaku Z, Gadissa T, Negash A, Hinderaker S, Harries A. Intensified tuberculosis case finding among people living with the human immunodeficiency virus in a hospital clinic in Ethiopia. Int J Tuberc Lung Dis 2011;15:411–3.
24. Kimerling ME, Schuchter J, Chanthol E, Kunthy T, Stuer F, Glaziou P, et al. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis 2002;6:988–94.
25. Jam S, Sabzvari D, SeyedAlinaghi S, Fattahi F, Jabbari H. Frequency of Mycobacterium tuberculosis infection among Iranian patients with HIV/AIDS by PPD test. Acta Med Iran 2010;48:67–71.
26. Sulis G, Roggi A, Matteelli A, Raviglione MC. Tuberculosis: epidemiology and control. Mediterr J Hematol Infect Dis 2014;6:e2014070.
27. Kufa T, Chihota V, Mngomezulu V, Charalambous S, Verver S, Churchyard G, et al. The incidence of tuberculosis among HIV-positive individuals with high CD4 counts: implications for policy. BMC Infect Dis 2016;16:266.
28. Kufa T, Mabuto T, Muchiri E, Charalambous S, Rosillon D, Churchyard G, et al. Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis. PLoS One 2014;9:e111209.
29. Nicholas S, Sabapathy K, Ferreyra C, Varaine F, Pujades-Rodríguez M, AIDS Working Group of Médecins Sans Frontières. Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs. J Acquir Immune Defic Syndr 2011;57:311–8.
30. Sadirova D, Grigoryan R, Parpieva N, Barotova V, Trubnikov A, Kalandarova L, et al. Incidence rate and risk factors for tuberculosis among people living with HIV: a 2015–2017 cohort from Tashkent, Uzbekistan. Int J Environ Res Public Health 2021;18:5746.
31. Camara BS, Delamou A, Diro E, Béavogui AH, El Ayadi AM, Sidibé S, et al. Effect of the 2014/2015 Ebola outbreak on reproductive health services in a rural district of Guinea: an ecological study. Trans R Soc Trop Med Hyg 2017;111:22–9.
32. Leuenberger D, Hebelamou J, Strahm S, De Rekeneire N, Balestre E, Wandeler G, et al. Impact of the Ebola epidemic on general and HIV care in Macenta, Forest Guinea, 2014. AIDS 2015;29:1883–7.
33. Madhu M, Udaya Kumar V, Dhingra S, Kumar N, Singh S, Ravichandiran V, et al. Nutritional aspects of people living with HIV amidst COVID-19 pandemic: an insight. Curr Pharmacol Rep 2022;8:350–64.
34. Enju L, Makubi A, Drain P, Spiegelman D, Sando D, Nan L, et al. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy in Tanzania. AIDS 2015;29:1391–9.
35. Moore D, Liechty C, Ekwaru P, Were W, Mwima G, Solberg P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS 2007;21:713–9.
36. UNAIDS. Global AIDS report 2016. Geneva: UNAIDS; 2016.
37. Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control study. PLoS One 2013;8:e64488.
38. Gupte AN, Kadam D, Sangle S, Rewari BB, Salvi S, Chavan A, et al. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India. BMC Infect Dis 2019;19:1–9.
39. Wachinou AP, Ade S, Agodokpessi G, Awanou B, Affolabi D, Bekou W, et al. Diagnosis and treatment outcomes of tuberculosis in relation to gender and HIV status in South Benin. J Tuberc Res 2017;5:189–200.
40. Abgrall S, Del Giudice P, Melica G, Costagliola D. HIV-associated tuberculosis and immigration in a high-income country: incidence trends and risk factors in recent years. AIDS 2010;24:763–71.
41. Karo B, Haas W, Kollan C, Gunsenheimer-Bartmeyer B, Hamouda O, Fiebig L, et al. Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors. BMC Infect Dis 2014;14:148.
42. Cui Z, Lin M, Nie S, Lan R. Risk factors associated with tuberculosis among people living with HIV/AIDS: a pair-matched case-control study in Guangxi, China. PLoS One 2017;12:e0173976.
43. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001;15:143–52.
44. Soares KA, Ehrlich J, Camará M, Chaloub S, Emeka E, Gando HG, et al. Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries. Eur Respir J 2023;62:2103053.
45. Shinde M, Dixit S, Patel M, Sharma A, Satam J, Patil Y, et al. Relationship between smoking and pulmonary tuberculosis based on positive sputum smears. GMS Hyg Infect Control 2024;19:Doc58.
46. Sujana SP, Hamda FH, Siddiq MA, Latif YI, Asyary A. The association between secondhand smoke exposure and risk of developing active tuberculosis in individuals with latent tuberculosis infection: a systematic literature review. Ann Ig 2025 doi: 10.7416/ai.2025.2685. Epub ahead of print.
Published
Issue
Section
License
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Mattioli 1885 has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
How to Cite
